{"version":"1.0","type":"link","title":"Evaluation of serum tumor markers in assessing the efficacy of TP (Paclitaxel plus Carboplatin) chemotherapy combined with trastuzumab and pertuzumab dual target therapy in HER2-positive breast cancer.","author_name":"Wang L 외","author_url":"https://prs-insight.online/author/Wang%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/87365","thumbnail_width":1200,"thumbnail_height":630}